# Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass

> **NCT03500783** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Bypass
- Cardiopulmonary Bypass
- Nitric Oxide
- Reperfusion Injury, Myocardial

## Interventions

- **DRUG:** Nitric Oxide
- **OTHER:** Standard CPB

## Key facts

- **NCT ID:** NCT03500783
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-15
- **Primary completion:** 2016-11-30
- **Final completion:** 2016-11-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03500783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03500783, "Nitric Oxide-mediated Cardioprotection During Cardiac Surgery With Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03500783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*